Analyst Update: Chemours, EP Energy, and Epizyme

Analysts adjusted their ratings and price targets on Chemours Co (CC), EP Energy Corp (EPE), and Epizyme Inc (EPZM)

Mar 14, 2016 at 3:13 PM
facebook X logo linkedin


Analysts are weighing in on chemical concern Chemours Co (NYSE:CC), oil-and-gas issue EP Energy Corp (NYSE:EPE), and drug stock Epizyme Inc (NASDAQ:EPZM). Here's a quick roundup of today's brokerage notes on CC, EPE, and EPZM.

  • CC has surged 6.6% to trade at $6.95, following an upgrade to "buy" from "neutral" at Goldman Sachs -- which also raised its price target to $10 from $6. Specifically, the brokerage firm said a bottoming titanium dioxide market could help the stock, as could the company's "cost cutting and asset optimization effort." Currently, Chemours Co is on track for its highest close since early November. If the shares can build on their recent momentum, additional upgrades could be in the cards, with 80% of analysts still rating them a "hold" or worse.
  • EPE is smarting on a downgrade to "accumulate" from "buy" at KLR, which cited the company's valuation as the basis of the negative note. Further contributing to the selling pressure is a drop in crude oil prices. At last check, EP Energy Corp has fallen 4.9% at $4.89, and has pulled back 34% from its near-term high of $7.44 touched one week ago. This certainly comes as a welcome development for short sellers. Despite short interest falling 11.3% during the latest reporting period, 13.6 million EPE shares are still sold short -- an amount that would take over one week to cover, at typical trading levels.
  • H.C. Wainwright bumped its rating on EPZM up to "buy," and increased its price target to $25. The move has the shares 8.1% higher at $11.15 -- though they remain 30% lower year-to-date. Nevertheless, short-term option traders are extremely call-skewed toward Epizyme Inc. The stock's Schaeffer's put/call open interest ratio (SOIR) checks in at an annual low of 0.15, with calls outstripping puts by a more than 6-to-1 basis among options with a shelf-life of three months or less.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Johnson & Johnson, Transocean LTD, and Tesla Motors Inc and Analyst Downgrades: Finish Line Inc, Hibbett Sports, Inc., and Clean Energy Fuels Corp.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI